Browsing Tag
Dr. Albert Bourla
3 posts
Pfizer and BioNTech’s Covid-19 vaccine candidate shows over 90% effectiveness in Phase 3 Trial
Pfizer and BioNTech have announced a groundbreaking update in their efforts to combat the Covid-19 pandemic. Their BNT162b2…
November 10, 2020
FTC grants conditional approval for Mylan’s acquisition of Upjohn: What this means for the pharma industry
The U.S. Federal Trade Commission (FTC) has granted conditional approval for Mylan’s acquisition of Upjohn, Pfizer’s off-patent branded…
October 31, 2020
BNT162 COVID-19 vaccine candidate : US govt signs $2bn supply deal with Pfizer and BioNTech
Pfizer and BioNTech have bagged a $1.95 billion deal with the US government for supplying 100 million doses…
July 22, 2020